BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16705546)

  • 1. The Leu7Pro polymorphism of neuropeptide Y is associated with younger age of onset of type 2 diabetes mellitus and increased risk for nephropathy in subjects with diabetic retinopathy.
    Jaakkola U; Pesonen U; Vainio-Jylhä E; Koulu M; Pöllönen M; Kallio J
    Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):147-52. PubMed ID: 16705546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the Leu7Pro polymorphism of preproNPY on diurnal NPY and hormone secretion in type 2 diabetes.
    Jaakkola U; Koulu M; Karvonen MK; Seppälä H; Pesonen U; Vahlberg T; Kallio J
    Exp Clin Endocrinol Diabetes; 2007 May; 115(5):281-6. PubMed ID: 17516289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with proteinuria, coronary heart disease, and glycemic control in type 1 diabetic patients.
    Pettersson-Fernholm K; Karvonen MK; Kallio J; Forsblom CM; Koulu M; Pesonen U; Fagerudd JA; Groop PH;
    Diabetes Care; 2004 Feb; 27(2):503-9. PubMed ID: 14747236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects.
    Ukkola O; Kesäniemi YA
    Eur J Clin Nutr; 2007 Sep; 61(9):1102-5. PubMed ID: 17268419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucine 7 to proline 7 polymorphism in the neuropeptide y gene is associated with retinopathy in type 2 diabetes.
    Niskanen L; Voutilainen-Kaunisto R; Teräsvirta M; Karvonen MK; Valve R; Pesonen U; Laakso M; Uusitupa MI; Koulu M
    Exp Clin Endocrinol Diabetes; 2000; 108(3):235-6. PubMed ID: 10926322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects.
    Niskanen L; Karvonen MK; Valve R; Koulu M; Pesonen U; Mercuri M; Rauramaa R; Töyry J; Laakso M; Uusitupa MI
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2266-9. PubMed ID: 10852461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Leu7Pro polymorphism of the signal peptide of neuropeptide Y (NPY) gene is associated with increased levels of inflammatory markers preceding vascular complications in patients with type 2 diabetes.
    Jaakkola U; Kakko T; Seppälä H; Vainio-Jylhä E; Vahlberg T; Raitakari OT; Kallio J
    Microvasc Res; 2010 Dec; 80(3):433-9. PubMed ID: 20691708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes.
    Ray D; Mishra M; Ralph S; Read I; Davies R; Brenchley P
    Diabetes; 2004 Mar; 53(3):861-4. PubMed ID: 14988276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Leu7Pro polymorphism of preproNPY is associated with decreased insulin secretion, delayed ghrelin suppression, and increased cardiovascular responsiveness to norepinephrine during oral glucose tolerance test.
    Jaakkola U; Kuusela T; Jartti T; Pesonen U; Koulu M; Vahlberg T; Kallio J
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3646-52. PubMed ID: 15797951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of neuropeptide Y Leu7Pro polymorphism in patients with type 1 diabetes and diabetic nephropathy among Swedish and American populations.
    Ma J; Nordman S; Möllsten A; Falhammar H; Brismar K; Dahlquist G; Efendic S; Gu HF
    Eur J Endocrinol; 2007 Nov; 157(5):641-5. PubMed ID: 17984244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients.
    Maeda M; Yamamoto I; Fukuda M; Motomura T; Nishida M; Nonen S; Fujio Y; Kasayama S; Azuma J
    J Diabetes Complications; 2008; 22(2):119-25. PubMed ID: 18280442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin I-converting enzyme and angiotensinogen gene polymorphisms in non-insulin-dependent diabetes mellitus. Lack of relationship with diabetic nephropathy and retinopathy in a Caucasian Mediterranean population.
    Gutiérrez C; Vendrell J; Pastor R; Llor C; Aguilar C; Broch M; Richart C
    Metabolism; 1997 Aug; 46(8):976-80. PubMed ID: 9258285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes.
    Wang Y; Ng MC; Lee SC; So WY; Tong PC; Cockram CS; Critchley JA; Chan JC
    Diabetes Care; 2003 Aug; 26(8):2410-5. PubMed ID: 12882871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y polymorphism significantly magnifies diabetes and cardiovascular disease risk in obesity: the Hoorn Study.
    Jaakkola U; Kallio J; Heine RJ; Nijpels G; T' Hart LM; Maassen JA; Bouter LM; Stehouwer CD; Dekker JM
    Eur J Clin Nutr; 2009 Jan; 63(1):150-2. PubMed ID: 18043699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men.
    Nordman S; Ding B; Ostenson CG; Kärvestedt L; Brismar K; Efendic S; Gu HF
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):282-7. PubMed ID: 15926114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization.
    Koulu M; Movafagh S; Tuohimaa J; Jaakkola U; Kallio J; Pesonen U; Geng Y; Karvonen MK; Vainio-Jylhä E; Pöllönen M; Kaipio-Salmi K; Seppälä H; Lee EW; Higgins RD; Zukowska Z
    Ann Med; 2004; 36(3):232-40. PubMed ID: 15181979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The -106CC genotype of the aldose reductase gene is associated with an increased risk of proliferative diabetic retinopathy in Caucasian-Brazilians with type 2 diabetes.
    dos Santos KG; Canani LH; Gross JL; Tschiedel B; Souto KE; Roisenberg I
    Mol Genet Metab; 2006 Jul; 88(3):280-4. PubMed ID: 16545977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in diurnal sympathoadrenal balance and pituitary hormone secretion in subjects with Leu7Pro polymorphism in the prepro-neuropeptide Y.
    Kallio J; Pesonen U; Jaakkola U; Karvonen MK; Helenius H; Koulu M
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3278-83. PubMed ID: 12843176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single-nucleotide polymorphism in the MicroRNA-146a gene is associated with diabetic nephropathy and sight-threatening diabetic retinopathy in Caucasian patients.
    Kaidonis G; Gillies MC; Abhary S; Liu E; Essex RW; Chang JH; Pal B; Sivaprasad S; Pefkianaki M; Daniell M; Lake S; Petrovsky N; Hewitt AW; Jenkins A; Lamoureux EL; Gleadle JM; Craig JE; Burdon KP
    Acta Diabetol; 2016 Aug; 53(4):643-50. PubMed ID: 26997512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes.
    Neugebauer S; Baba T; Watanabe T
    Diabetes; 2000 Mar; 49(3):500-3. PubMed ID: 10868974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.